GLAXOSMITHKLINE PLC

Average Profitability
<0.0001%
Insider Buys Quantity
20
Insider Buys Sum
$639.56M
Insider Sells Quantity
11
Insider Sells Sum
$3.02B

Insider Activity of GLAXOSMITHKLINE PLC

According to the SEC Form 4 filings, GLAXOSMITHKLINE PLC, being in a position of

  1. 10 percent owner at Wave Life Sciences Ltd.,
    оver the last 12 months, has bought 2791930 shares for $22.34M, and sold 0 shares,
    over all time since 2023-12-07, has bought 6091930 shares for $38.84M, and sold 0 shares.

The largest purchase of all time was on 2010-11-29 and amounted to 11500000 shares of Innoviva, Inc. for $258.75M.

The largest sale of all time was on 2011-01-31 and amounted to 30755151 share of Quest Diagnostics Incorporated for $1.69B.

Biography of GLAXOSMITHKLINE PLC

No biography is available at this moment.

2024-09-27PurchaseWave Life Sciences Ltd.
WVE
10 percent owner
2.79M
2.2327%
$8.00$22.34M+72.44%
2023-12-07PurchaseWave Life Sciences Ltd.
WVE
10 percent owner
3.3M
3.4922%
$5.00$16.5M+21.88%
2021-07-02PurchaseCVRx, Inc.
CVRX
10 percent owner
550,000
1.932%
$18.00$9.9M-56.83%
2021-05-20SaleInnoviva, Inc.
INVA
10 percent owner
32.01M
33.288%
$12.25$392.06M+23.35%
2020-07-15SaleBicycle Therapeutics plc
BCYC
10 percent owner
6,294
0.0326%
$19.40$122,090+13.66%
2020-07-14SaleBicycle Therapeutics plc
BCYC
10 percent owner
3,194
0.0166%
$19.27$61,561+11.13%
2020-07-14PurchaseNkarta, Inc.
NKTX
1.67M
2.6861%
$18.00$30M-11.28%
2020-05-20SaleProgyny, Inc.
PGNY
10 percent owner
8M
9.469%
$25.75$206M+19.93%
2019-05-28PurchaseBicycle Therapeutics plc
BCYC
771,428
12.0507%
$14.00$10.8M-13.68%
2018-07-30PurchaseLiquidia Corporation
LQDA
Former 10% holder
148,818
1.2822%
$11.00$1.64M+38.27%
2018-07-17PurchaseSpero Therapeutics, Inc.
SPRO
10 percent owner
80,000
0.4892%
$12.50$1M-6.41%
2017-11-06PurchaseSpero Therapeutics, Inc.
SPRO
10 percent owner
428,571
5.3915%
$14.00$6M-3%
2016-10-24PurchaseCRISPR Therapeutics AG
CRSP
10 percent owner
133,000
1.0843%
$14.00$1.86M+31.44%
2014-10-27SaleAmicus Therapeutics, Inc.
FOLD
22.63M
28.0717%
$5.29$119.74M+86.13%
2013-11-20PurchaseAmicus Therapeutics, Inc.
FOLD
Former 10% Owner (1)
1.5M
2.1989%
$2.00$3M+29.25%
2012-08-03PurchaseInnoviva, Inc.
INVA
10 percent owner
316,334
0.4537%
$28.21$8.92M-8.32%
2012-07-17PurchaseAmicus Therapeutics, Inc.
FOLD
Former 10% Owner (1)
2.95M
6.3627%
$6.30$18.58M-38.62%
2012-05-16PurchaseInnoviva, Inc.
INVA
10 percent owner
10M
14.8687%
$21.29$212.89M+9.68%
2012-02-14PurchaseInnoviva, Inc.
INVA
10 percent owner
176,936
0.2829%
$18.12$3.21M+21.27%
2011-11-01PurchaseInnoviva, Inc.
INVA
10 percent owner
116,822
0.1996%
$22.23$2.6M+3.12%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.